U. Lassen, L. Henrik Jensen, M. Sorensen, K. S. Rohrberg, Z. Ujmajuridze, and A. Jakobsen, “A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas”, AO, vol. 50, no. 3, pp. 448–454, Apr. 2011.